Levi & Korsinsky Urges Shareholders: Don’t Miss Your Chance to Lead a Significant Lawsuit – Important Deadline Approaching

Micron Technology Investors: Understanding Your Rights and Potential Recovery After a Loss Investing in the stock market comes with inherent risks, and even the most carefully selected investments can experience significant losses. One such investment that has seen a decline in value is Micron Technology, Inc. (NASDAQ: MU). If you find yourself among the affected…

Read More

One-Third of Americans Admit to Having Zero Retirement Savings: BlackRock and Bipartisan Policy Center Host National Summit to Discuss Solutions in D.C.

Retiring with Dignity: A Dream Slipping Away for Millions Washington D.C. – In an alarming revelation, BlackRock, a leading global investment management corporation, has recently released the findings of a survey that paints a concerning picture of Americans’ retirement readiness. The survey, which polled 1,000 national registered voters, exposes a retirement savings crisis that is…

Read More

Tarsus’ 2024 Financial Results: Get the Scoop on Their Q4 Numbers, Coming Your Way on February 25, 2025! 📊💰 #TarsusInc

Tarsus Pharmaceuticals: A Peek into Their Q4 2024 Financial Results and Corporate Update Get ready for a scintillating journey into the world of Tarsus Pharmaceuticals, where numbers, drugs, and corporate updates come together in a delightful blend! But before we dive in, let’s set the stage. Imagine a sunny morning in Irvine, California, where the…

Read More

SHLS Alert: Levi & Korsinsky Investigates Losses for Shareholders of Shoals Technologies Group Inc.

Levi & Korsinsky Investigates Shoals Technologies Group, Inc. for Securities Violations Overview New York, NY / ACCESSWIRE / October 28, 2024 / Levi & Korsinsky has initiated an investigation into Shoals Technologies Group, Inc. (NASDAQ: SHLS) for potential breaches of federal securities laws. The probe focuses on allegations that Shoals and certain company executives failed…

Read More

ALX Oncology’s 2024 Financial Year Wrap-Up: Get Ready for the Big Reveal on March 6, 2025

ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results South San Francisco, CA – ALX Oncology Holdings Inc. (“ALX Oncology” or the “Company”), a pioneering biotechnology company specializing in immunotherapy to combat cancer and enhance patients’ survival, has announced its intention to release the financial results for the fourth quarter and the…

Read More